NEW YORK, Feb. 15 (GenomeWeb News) - Sigma-Aldrich yesterday reported a 16.7-percent increase in revenues and a 4.8-percent rise in net income for the fourth quarter.
Sales for the three months ended Dec. 31, 2005, rose to $410.5 million from $351.9 million in the year-ago period. The company's scientific research and biotechnology business units increased by 2.7 percent and 12.5 percent, respectively, year over year.
R&D expenses for the fourth quarter grew 10 percent to $12.2 million from $11.1 million in Q4 2004, Sigma-Aldrich said.
Sigma-Aldrich's net income for the fourth quarter grew to $57.3 million from $54.7 million in Q4 2004.
As of Dec. 31, Sigma-Aldrich had approximately $98.6 million in cash and cash equivalents.